Hamilton H W, Ortwine D F, Worth D F, Badger E W, Bristol J A, Bruns R F, Haleen S J, Steffen R P
J Med Chem. 1985 Aug;28(8):1071-9. doi: 10.1021/jm00146a016.
A set of 56 8-phenylxanthines, previously tested for adenosine antagonism (adenosine A1 receptor affinity), was analyzed by quantitative structure-activity relationship (QSAR) techniques. The resulting QSAR revealed that (1) the most potent receptor binders had already been made in this series and thus suggested the termination of synthesis of compounds with additional phenyl substituents to increase potency and (2) potency was much more strongly affected by changes in ortho than para phenyl substitution. On the basis of this study, an additional 20 compounds were synthesized that contained primarily para substituents designed to increase aqueous solubility. High potency was maintained among the resulting sulfonamide derivatives (as predicted by the QSAR), and aqueous solubility was dramatically increased. Furthermore, in vitro antagonism of an adenosine receptor mediated physiological effect was demonstrated.
一组先前已针对腺苷拮抗作用(腺苷A1受体亲和力)进行测试的56种8-苯基黄嘌呤,通过定量构效关系(QSAR)技术进行了分析。所得的QSAR表明:(1)该系列中已制得最有效的受体结合剂,因此建议终止合成带有额外苯基取代基以提高效力的化合物;(2)邻位苯基取代的变化对效力的影响远比对位苯基取代的影响大。基于这项研究,合成了另外20种化合物,这些化合物主要含有旨在增加水溶性的对位取代基。所得的磺酰胺衍生物保持了高效力(如QSAR所预测),并且水溶性显著增加。此外,还证明了对腺苷受体介导的生理效应的体外拮抗作用。